Professional
Added to YB: 2024-03-01
Pitch date: 2024-02-02
NTRA [bullish]
Natera, Inc.
+205.18%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
Market Cap
$28.8B
Pitch Price
$67.13
Price Target
N/A
Dividend
N/A
EV/EBITDA
-111.11
P/E
-133.35
EV/Sales
12.10
Sector
Biotechnology
Category
growth
Show full summary:
RiverPark/Next Century Growth Fund New Position: Natera, Inc.
$NTRA: Leader in cell-free DNA tests for oncology, women's & organ health. Signatera addresses min residual disease in cancer. Consistent rev growth, nearing positive cash flow after years of investment. Aims to integrate personalized genetic testing into standard of care.
Read full article (1 min)